Eli Lilly, Applied NeuroSolutions in AD deal

LLY and APNS partnered to develop therapeutics to treat Alzheimer's disease. LLY will have exclusive rights to APNS's IP related to the molecular neuropathology of AD as it pertains to the formation o...